Albaconazole (development code UR-9825) is an experimental triazole antifungal.[1] It has potential broad-spectrum activity. The drug blocks a number of CYP450 liver enzymes.[citation needed]

Albaconazole
Clinical data
ATC code
  • none
Identifiers
  • 7-Chloro-3-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]quinazolin-4-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.170.829 Edit this at Wikidata
Chemical and physical data
FormulaC20H16ClF2N5O2
Molar mass431.83 g·mol−1
3D model (JSmol)
  • Fc1ccc(c(F)c1)[C@](O)([C@H](N3\C=N/c2cc(Cl)ccc2C3=O)C)Cn4ncnc4
  • InChI=1S/C20H16ClF2N5O2/c1-12(28-11-25-18-6-13(21)2-4-15(18)19(28)29)20(30,8-27-10-24-9-26-27)16-5-3-14(22)7-17(16)23/h2-7,9-12,30H,8H2,1H3/t12-,20-/m1/s1 checkY
  • Key:UHIXWHUVLCAJQL-MPBGBICISA-N checkY
  (verify)

It has also been studied as an antiprotozoal agent.[2]

References

edit
  1. ^ "Albaconazole". Adis Insight. Springer Nature Switzerland AG.
  2. ^ Guedes PM, Urbina JA, de Lana M, Afonso LC, Veloso VM, Tafuri WL, et al. (November 2004). "Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts". Antimicrobial Agents and Chemotherapy. 48 (11): 4286–92. doi:10.1128/AAC.48.11.4286-4292.2004. PMC 525424. PMID 15504854.